FirstString Research

FirstString Research

FirstString Research | healing power.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor investor investor

€0.0

round
N/A

€0.0

round
investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
N/A

€0.0

Valuation: €0.0

round
N/A

$26.7m

Series D
Total Funding000k
Notes (0)
More about FirstString Research
Made with AI
Edit

FirstString Research is a biopharmaceutical company specializing in the development of innovative therapies for wound healing and tissue regeneration. The company operates in the healthcare and biotechnology market, targeting patients with chronic wounds, surgical wounds, and other tissue repair needs. FirstString Research employs a business model focused on research and development, clinical trials, and partnerships with healthcare providers and pharmaceutical companies. Revenue is generated through the commercialization of its proprietary therapies, licensing agreements, and strategic collaborations. The company serves a diverse client base, including hospitals, clinics, and healthcare professionals, aiming to improve patient outcomes and quality of life.

Keywords: biopharmaceutical, wound healing, tissue regeneration, chronic wounds, surgical wounds, healthcare, biotechnology, clinical trials, proprietary therapies, strategic collaborations.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo